drugset / Trial / NCT00136175
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy and safety of combination chemotherapy (paclitaxel, carboplatin, and gemcitabine) prior to surgery in the treatment of patients with locally advanced transitional cell cancer of the bladder.
Timeline
- Start
- 1999-11
- Primary completion
- 2005-12
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Gemcitabine | Small molecule | 800 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 200 mg/m2 | — |